Founded in The Woodlands, United States, EpiCypher is a pioneering bioscience company dedicated to advancing the field of epigenetics and chromatin biology. Their core mission is to develop transformative technologies that aid researchers worldwide in understanding and manipulating the epigenome. EpiCypher offers a range of innovative products and services, including recombinant nucleosomes, modified histones, and cutting-edge assays, all designed to facilitate groundbreaking research in epigenetics.
EpiCypher has garnered attention from notable scientists and investors in the bioscience community, contributing significantly to advancements in epigenetic research. Their key achievements include the development of proprietary technologies like SNAP-ChIP and dCypher, which have become essential tools for researchers. The company's impact is evident in its widespread adoption by leading research institutions and its role in driving forward the understanding of gene regulation and disease mechanisms.
